A study was conducted to determine the effects of graded levels of dietary inclusion of a cysteamine (Cs) preparation on growth performance, carcass quality, plasma hormone levels, gastric pH and occurrence of gastric ulcer in finishing pigs. A total of 384 Landrace × Large White finishing pigs, (192 gilts and 192 barrows) with an average initial body weight of 66.05 ± 0.623 kg (mean ± SEM) were randomly divided into 24 floor pens, with eight gilts and eight barrows in each pen (9.2 m 2 ) as one experimental unit. The 24 pens of pigs were randomly allocated to one of three diets: (1) a maize/soybean meal basal diet; (2) the basal diet plus 30 mg Cs kg −1 diet; and (3) the basal diet plus 50 mg Cs kg −1 diet. Dietary supplementation of Cs had quadratic effects (P < 0.01) on final body weight and average daily gain, with optimal responses occurring at 30 mg kg −1 . Dietary supplementation of Cs quadratically improved (P < 0.01) average daily feed intake and feed/gain ratio, with optimal responses occurring at 30 mg kg −1 . Dietary supplementation of Cs had a quadratic effect (P < 0.01) on muscle RNA/DNA ratio. Furthermore, dietary supplementation of Cs reduced (P < 0.05) back-fat thickness. Dietary supplementation of Cs had quadratic effects (P < 0.05) on plasma glucagon and T 3 hormone levels, with optimal responses occurring at 30 mg kg −1 , but had no effect (P > 0.05) on plasma growth hormone, insulin and T 4 levels. There were no apparent pathological changes seen in the stomach mucosa of pigs fed at 30 mg Cs kg −1 compared with the control diet. It is concluded that a low dose of dietary inclusion of Cs at 30 mg kg −1 can improve growth performance and carcass quality without adverse effects on the stomach in finishing pigs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.